Related Experiment Videos
A novel approach for personalized response model: deep learning with individual dropout feature ranking
Ruihao Huang1, Qi Liu2, Ge Feng1
1Department of Mathematical Sciences, Michigan Technological University, Houghton, MI, USA.
Journal of Pharmacokinetics and Pharmacodynamics
|October 26, 2020
Summary
This study introduces a novel deep learning model for feature ranking in AI. The individual level dropout feature ranking model enhances interpretability in biology and healthcare, enabling personalized medicine.
Area of Science:
- Artificial Intelligence
- Machine Learning
- Bioinformatics
Background:
- Deep learning (DL) offers transformative innovations but lacks interpretability in biology and healthcare.
- Interpretability is crucial for hypothesis-driven research and clinical applications.
Purpose of the Study:
- Propose a novel DL model with individual feature ranking for enhanced interpretability.
- Compare its performance against existing models using simulated and clinical data.
- Enable identification of impactful features at the individual patient level.
Main Methods:
- Developed a novel deep learning model incorporating individual level dropout feature ranking.
- Utilized simulated datasets with correlated and buried features to test the model.
- Applied the model to a publicly available clinical dataset.
- Compared performance against Artificial Neural Network, Random Forest, and population level dropout models.
Main Results:
- The individual level dropout feature ranking model demonstrated reasonable prediction accuracy.
- It successfully identified impactful features at the individual level, unlike population-level models.
- This approach allows for patient subgroup identification based on feature impact.
Conclusions:
- The proposed model enhances DL interpretability in complex datasets.
- It facilitates personalized medicine by identifying individual-specific impactful features.
- This offers a new tool for patient stratification in clinical drug development and personalized therapies.